An Observational Study For Ambrisentan (VOLT)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Hypertension, Pulmonary

Treatments: Drug: ambrisentan

Study type: Observational

Funder types: Industry

Identifiers

NCT00679224

110094

Details and patient eligibility

About

The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

Full description

The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

Enrollment: 800 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

subjects who have been prescribed ambrisentan for a medically appropriate use (see approved product label)

Trial design

800 participants in 1 patient group

ambrisentan prescribed subjects

Description:

ambrisentan prescribed subjects

Treatment:

Drug: ambrisentan